|4Mar 14, 9:40 AM ET

Downs Christopher 4

4 · CNS Pharmaceuticals, Inc. · Filed Mar 14, 2022

Insider Transaction Report

Form 4
Period: 2022-03-11
Downs Christopher
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-03-11$0.31/sh+33,000$10,230184,500 total

Documents

1 file
  • 4
    ownership.xmlPrimary